Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,383
datasets available to search
ShareScore release 0.9.0
Dataset results
1,383 results for “Estrogen”
Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy
ClinicalTrials.gov study NCT02691936. IPD Sharing: YES. Countries: 1. Publications: 2.
The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides
ClinicalTrials.gov study NCT02524769. IPD Sharing: NO. Countries: 1. Publications: 17.
Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy
ClinicalTrials.gov study NCT00956813. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and
ClinicalTrials.gov study NCT04436744. IPD Sharing: YES. Countries: 11. Publications: 1.
Clinical Trial of Estrogen for Postpartum Depression
ClinicalTrials.gov study NCT00059228. IPD Sharing: Not stated. Countries: 1. Publications: 3.
The Effects of Aging and Estrogen on the Pituitary
ClinicalTrials.gov study NCT00386022. IPD Sharing: YES. Countries: 1. Publications: 2.
A Randomized, Single Center Pilot Study Comparing Hyaluronic Acid to Vaginal Estrogen for Treatment of Genitourinary Syndrome of Menopause
ClinicalTrials.gov study NCT04544475. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer
ClinicalTrials.gov study NCT04288089. IPD Sharing: YES. Countries: 2. Publications: 1.
Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT02648477. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth F
ClinicalTrials.gov study NCT04109066. IPD Sharing: Not stated. Countries: 32. Publications: 2.
A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastroz
ClinicalTrials.gov study NCT01381874. IPD Sharing: Not stated. Countries: 12. Publications: 1.
Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen
ClinicalTrials.gov study NCT02431897. IPD Sharing: Not stated. Countries: 1. Publications: 6.
A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positiv
ClinicalTrials.gov study NCT01823835. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Meta
ClinicalTrials.gov study NCT00463788. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT03633331. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer
ClinicalTrials.gov study NCT02630693. IPD Sharing: YES. Countries: 1. Publications: 1.
Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women
ClinicalTrials.gov study NCT01958073. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Estrogen and Serotonin on Changing Brain Chemistry
ClinicalTrials.gov study NCT01208324. IPD Sharing: NO. Countries: 1. Publications: 5.
Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function
ClinicalTrials.gov study NCT03493126. IPD Sharing: NO. Countries: 1. Publications: 5.
Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women
ClinicalTrials.gov study NCT00592839. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.